Remove stories behind-the-science
article thumbnail

ISSCR launches new podcast

Scienmag

The Stem Cell Report with Martin Pera highlights the stories behind impactful science Credit: Credit: ISSCR Skokie, IL – The International Society for Stem Cell Research (ISSCR) unveils a new podcast today in connection with the Society’s open-access, peer-reviewed scientific journal, Stem Cell Reports.

article thumbnail

Pfizer Airs ‘Here’s to Science’ Commercial at Super Bowl 2024 Celebrating Scientists and 175 Years of Pfizer

XTalks

Pfizer was in attendance at Super Bowl 2024 to tell the story of science with its TV commercial ‘Here’s to Science.’ Pfizer’s ‘Here’s to Science’ commercial journeying through science ends off with Pfizer promising to take on “the next fight,” which for the company is cancer.

Scientist 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Twill taps YourCoach for DtX-health coaching integration

pharmaphorum

Eugene Borukhovich, YourCoach’s chief operating officer and other cofounder, says the impetus behind the partnership is to simply reach more people, and to leverage the strengths of each company. “Our If you liked this news story, check out the related video below. Not as long as coaching, but on its own, it’s pretty amazing.

Doctors 136
article thumbnail

Big data and cell therapy development: the pharmaphorum podcast

pharmaphorum

Darrin discusses the story behind Mogrify’s technology and his career journey with gene editing company Horizon Discovery Group Plc which was acquired by PerkinElmer in 2020. In the latest episode of the podcast pharmaphorum’s website editor Catherine Longworth speaks with Dr Darrin Disley, who’s the CEO of Mogrify.

article thumbnail

The FDA and Aduhelm: WTF?

World of DTC Marketing

Source: STAT News Our healthcare system can’t continue to support drugs that don’t have good clinical outcomes behind them. In my career in healthcare marketing, I have done my best to understand the “sciencebehind certain health conditions along with how some medications can help. government.

Drugs 218
article thumbnail

Why VCs fell in love with pharma R&D in 2021

pharmaphorum

For many years, those inside the pharma industry have been telling the same old story about innovation: pharma is big, slow, and risk averse. The risk equation changed for things like decentralised clinical trials, with companies that lacked the capacity for these trials falling behind. Start-ups move fast and break things.

article thumbnail

The building blocks of AI success stories

Drug Discovery World

However, we’re still a couple of years early for general purpose AI in science. The building blocks for AI success So, what needs to happen to ensure that AI is a technological success story in the future? The building blocks for AI success So, what needs to happen to ensure that AI is a technological success story in the future?

In-Vivo 52